Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78 | -30 | -60 | 100 | 153 |
| Depreciation Amortization | 30 | 31 | 26 | 28 | 20 |
| Accounts receivable | -328 | 463 | -701 | 2,150 | -2,170 |
| Accounts payable and accrued liabilities | -4 | -490 | 464 | -924 | 963 |
| Other Working Capital | -390 | 97 | -200 | 1,227 | -901 |
| Other Operating Activity | 348 | 46 | 255 | -1,218 | 1,267 |
| Operating Cash Flow | $-265 | $117 | $-216 | $1,363 | $-669 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -32 | -39 | -26 | -24 |
| Other Investing Activity | 1 | 6 | -9 | 5 | 6 |
| Investing Cash Flow | $-17 | $-26 | $-48 | $-22 | $-18 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Beginning Cash Position | 2,450 | 2,360 | 2,623 | 1,281 | 1,968 |
| End Cash Position | 2,168 | 2,450 | 2,360 | 2,623 | 1,281 |
| Net Cash Flow | $-282 | $91 | $-264 | $1,342 | $-687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -265 | 117 | -216 | 1,363 | -669 |
| Capital Expenditure | -18 | -32 | -39 | -26 | -24 |
| Free Cash Flow | -283 | 85 | -255 | 1,337 | -694 |